Pharvaris (PHVS) Change in Receivables (2020 - 2026)
Pharvaris (PHVS) posted Change in Receivables of -$335027.6 for Q1 2026, up 26.04% on a QoQ basis from -$453000.3 in Q4 2025, and down 154.22% year-over-year from $617925.2 in Q1 2025.
Pharvaris (PHVS) Change in Receivables (2020 - 2026) Analysis & Trends
Pharvaris' Change in Receivables history runs 7 years deep, the most recent figure standing at -$335027.6 for Q1 2026.
- Quarterly Change in Receivables fell 154.22% year-over-year to -$335027.6 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$575873.1 (down 141.79% YoY) and the FY2025 annual result came in at -$374350.5, down 907.9% from the prior year.
- Change in Receivables was -$335027.6 for Q1 2026 at Pharvaris, up from -$453000.3 in the prior quarter.
- Across five years, Change in Receivables topped out at $52.5 billion in Q2 2023 and bottomed at -$52.4 billion in Q3 2023.
- A 5-year average of $919811.0 and a median of -$12465.8 in 2023 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 14582576.89% in 2023, while the deepest fall reached 72003334.17% in 2023.
- Pharvaris' Change in Receivables stood at $22127.1 in 2022, then slumped by 657.61% to -$123382.3 in 2023, then soared by 262.44% to $200423.6 in 2024, then tumbled by 326.02% to -$453000.3 in 2025, then gained by 26.04% to -$335027.6 in 2026.
- Business Quant data shows PHVS's Change in Receivables at -$335027.6 in Q1 2026, -$453000.3 in Q4 2025, and $153880.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharvaris | 2.17 Bn | 1.88 Bn | - | -335,027.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -335,027.60 |
| Mar 31, 2026 | -335,027.60 |
| Dec 31, 2025 | -453,000.34 |
| Dec 31, 2025 | -453,000.34 |
| Sep 30, 2025 | 153,880.38 |
| Sep 30, 2025 | 153,880.38 |
| Jun 30, 2025 | 58,274.42 |
| Jun 30, 2025 | 58,274.42 |
| Mar 31, 2025 | -131,787.45 |
| Mar 31, 2025 | -131,787.45 |
| Dec 31, 2024 | 200,423.62 |
| Dec 31, 2024 | 200,423.62 |
| Sep 30, 2024 | -142,865.18 |
| Sep 30, 2024 | -142,865.18 |
| Jun 30, 2024 | -163,937.83 |
| Jun 30, 2024 | -163,937.83 |
| Mar 31, 2024 | 65,667.31 |
| Mar 31, 2024 | 65,667.31 |
| Dec 31, 2023 | -123,382.33 |
| Dec 31, 2023 | -123,382.33 |